China has launched PUMCH-GENESIS, an AI model designed to speed up and improve the diagnosis of rare genetic diseases. Developed with the Chinese Academy of Sciences, it helps detect conditions, recommend specialists, and manage appointments.
China has introduced an AI model, PUMCH-GENESIS, to enhance the diagnosis of rare genetic diseases, state media reported.
According to Xinhua news agency, the model accelerates and improves diagnoses, addressing delays and misdiagnoses that can be critical for patients. It identifies possible rare genetic or neurodevelopmental conditions and provides medical recommendations, including specialist consultations and necessary tests.
Currently, it handles preliminary diagnoses and appointment bookings, with future plans to support medical note generation, genetic interpretation, and hereditary counseling.
Developed with the Chinese Academy of Sciences and Peking Union Medical College Hospital (PUMCH), the AI is in its trial phase and is expected to be integrated into PUMCH’s online rare disease clinic.
Iran has opened the first phase of its largest solar power plant as part of a major government programme to expand renewable energy capacity....
UK authorities have raised an amber heat health alert for much of southern England, warning that the ongoing heatwave could lead to a rise in deaths....
Floods driven by climate change are raising the danger of long-banned toxic chemicals resurfacing in rivers, soil, and food chains, according to a new...
A group of high-profile British political figures and commentators has threatened legal action to block the return of the Elgin Marbles to Greece, acc...
A rocket launched by Taiwanese company TiSpace from Japan's northern Hokkaido island failed shortly after takeoff on Saturday, falling short of its go...
Nvidia has made history as the first publicly traded company to surpass a $4 trillion market value, driven by an AI-fuelled investor boom.
An impostor used artificial intelligence to mimic Secretary of State Marco Rubio’s voice and writing style, contacting top U.S. and foreign officials in a bold deception campaign.
Huawei’s AI research unit has rejected allegations that its Pangu Pro Moe model copied Alibaba’s Qwen 2.5, insisting it was independently developed.
The European Commission has dismissed industry calls to delay the rollout of its landmark AI Act, confirming that the law will proceed according to its legally established timeline.
A series of earthquakes have struck Guatemala on Tuesday afternoon, leading authorities to advise residents to evacuate from buildings as a precaution against possible aftershocks.
A deadly mass shooting early on Monday (7 July) in Philadelphia's Grays Ferry neighbourhood left three men dead and nine others wounded, including teenagers, as more than 100 shots were fired.
Australian researchers have created a groundbreaking “biological AI” platform that could revolutionise drug discovery by rapidly evolving molecules within mammalian cells.
Dozens of international and domestic flights were cancelled or delayed after Mount Lewotobi Laki Laki erupted on Monday, but Bali’s main airport remains operational.
French member of parliament Olivier Marleix was found dead at his home on Monday, with suicide being considered a possible cause.
Iran has opened the first phase of its largest solar power plant as part of a major government programme to expand renewable energy capacity.
A rocket launched by Taiwanese company TiSpace from Japan's northern Hokkaido island failed shortly after takeoff on Saturday, falling short of its goal to become the first foreign firm to complete a successful launch from Japanese soil.
Around 2,145 senior-ranking employees at the U.S. National Aeronautics and Space Administration (NASA) are set to leave under a push to shed staff, Politico reported on Wednesday citing documents obtained by the news outlet.
A woman from Guadeloupe has become the only known person in the world with a newly discovered blood group, which French scientists have named “Gwada negative.”
Australian researchers have created a groundbreaking “biological AI” platform that could revolutionise drug discovery by rapidly evolving molecules within mammalian cells.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment